Literature DB >> 2230644

Prooxidant activity of transferrin and lactoferrin.

S J Klebanoff1, A M Waltersdorph.   

Abstract

Acceleration of the autoxidation of Fe2+ by apotransferrin or apolactoferrin at acid pH is indicated by the disappearance of Fe2+, the uptake of oxygen, and the binding of iron to transferrin or lactoferrin. The product(s) formed oxidize iodide to an iodinating species and are bactericidal to Escherichia coli. Toxicity to E. coli by FeSO4 (10(-5) M) and human apotransferrin (100 micrograms/ml) or human apolactoferrin (25 micrograms/ml) was optimal at acid pH (4.5-5.0) and with logarithmic phase organisms. Both the iodinating and bactericidal activities were inhibited by catalase and the hydroxyl radical (OH.) scavenger mannitol, whereas superoxide dismutase was ineffective. NaCl at 0.1 M inhibited bactericidal activity, but had little or no effect on iodination. Iodide increased the bactericidal activity of Fe2+ and apotransferrin or apolactoferrin. The formation of OH.was suggested by the formation of the OH.spin-trap adduct (5,5-dimethyl-1-pyroline N-oxide [DMPO]/OH)., with the spin trap DMPO and the formation of the methyl radical adduct on the further addition of dimethyl sulfoxide. (DMPO/OH).formation was inhibited by catalase, whereas superoxide dismutase had little or no effect. These findings suggest that Fe2+ and apotransferrin or apolactoferrin can generate OH.via an H2O2 intermediate with toxicity to microorganisms, and raise the possibility that such a mechanism may contribute to the microbicidal activity of phagocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2230644      PMCID: PMC2188654          DOI: 10.1084/jem.172.5.1293

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  65 in total

1.  The effect of pH upon human transferrin: selective labelling of the two iron-binding sites.

Authors:  A N Lestas
Journal:  Br J Haematol       Date:  1976-03       Impact factor: 6.998

2.  A bactericidal effect for human lactoferrin.

Authors:  R R Arnold; M F Cole; J R McGhee
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

3.  Lactoferrin and transferrin: a comparative study.

Authors:  P Aisen; A Leibman
Journal:  Biochim Biophys Acta       Date:  1972-02-29

4.  Does transferrin exhibit ferroxidase activity?

Authors:  G W Bates; E F Workman; M R Schlabach
Journal:  Biochem Biophys Res Commun       Date:  1973-01-04       Impact factor: 3.575

5.  Inhibition of bacteria by lactoferrin and other iron-chelating agents.

Authors:  J D Oram; B Reiter
Journal:  Biochim Biophys Acta       Date:  1968-12-23

6.  Isolation and characterization of rabbit serum and milk transferrins. Evidence for difference in sialic acid content only.

Authors:  E Baker; D C Shaw; E H Morgan
Journal:  Biochemistry       Date:  1968-04       Impact factor: 3.162

7.  Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus.

Authors:  P L Masson; J F Heremans; J J Prignot; G Wauters
Journal:  Thorax       Date:  1966-11       Impact factor: 9.139

8.  Fate of human lactoferrin and myeloperoxidase in phagocytizing human neutrophils: effects of immunoglobulin G subclasses and immune complexes coated on latex beads.

Authors:  M S Leffell; J K Spitznagel
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

9.  Iron-binding proteins in milk and resistance to Escherichia coli infection in infants.

Authors:  J J Bullen; H J Rogers; L Leigh
Journal:  Br Med J       Date:  1972-01-08

10.  Facilitation of Fe(II) autoxidation by Fe(3) complexing agents.

Authors:  D C Harris; P Aisen
Journal:  Biochim Biophys Acta       Date:  1973-11-02
View more
  6 in total

1.  Lactoferrin regulates an axis involving CD11b and CD49d integrins and the chemokines MIP-1α and MCP-1 in GM-CSF-treated human primary eosinophils.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Interferon Cytokine Res       Date:  2012-06-25       Impact factor: 2.607

2.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.

Authors:  T Kawamata; I Tooyama; T Yamada; D G Walker; P L McGeer
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

3.  Identification and purification of transferrin- and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica.

Authors:  F D Menozzi; C Gantiez; C Locht
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease.

Authors:  Li An; Haruhisha Sato; Yoshihiro Konishi; Douglas G Walker; Thomas G Beach; Joseph Rogers; Ikuo Tooyama
Journal:  Neurosci Lett       Date:  2009-02-04       Impact factor: 3.046

5.  Alterations in neonatal neutrophil function attributable to increased immature forms.

Authors:  Marjorie Makoni; Jeffrey Eckert; H Anne Pereira; Victor Nizet; Shelley M Lawrence
Journal:  Early Hum Dev       Date:  2016-07-16       Impact factor: 2.079

6.  Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients.

Authors:  George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.